Clinical Outcome of Ayurvedic Treatment in Adenomyosis: Perspective of Vataja Asrigdara

In: AYUSHDHARA · 2026 · pp. 486–489 · doi:10.47070/ayushdhara.v13i1.2519 · W7151242376
article OA: diamond CC0

Abstract

Adenomyosis is a benign but debilitating gynaecological condition characterized by ectopic endometrial tissue within the myometrium, often presenting with dysmenorrhea, heavy menstrual bleeding, and infertility. Ayurveda describes a comparable condition under Vataja Asrigdara, attributed to Dushti of Vata, Pitta, and Rakta. Integrative Ayurvedic management has shown promise in reducing symptoms and improving uterine health. Case Presentation: A 36-year-old married woman presented with severe dysmenorrhea, heavy menstrual bleeding, and pelvic heaviness for 18 months. Transvaginal ultrasound reported a bulky uterus with asymmetric thickening of the posterior myometrium suggestive of adenomyosis. Intervention: She underwent an integrative Ayurvedic protocol comprising Deepana-Pachana, Vatanulomana, Raktashodhaka drugs, Nasya, and Basti Krama. Diet and lifestyle guidelines following Vata-Pitta Shamaka principles were advised. Results: Within 90 days, the patient showed marked reduction in pain score on the VAS scale, decrease in menstrual blood loss (PBAC score), improved haemoglobin, and reduction in uterine volume on ultrasound. Conclusion: This case demonstrates that an integrative Ayurvedic approach can significantly improve clinical symptoms and uterine morphology in adenomyosis, offering a non-invasive therapeutic option. Larger controlled studies are required.

My notes (saved in your browser only)

Outcome instruments

VAS-pain

Condition tags

adenomyosisdysmenorrheainfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-14T06:02:12.833719+00:00
License: CC0 · commercial use OK